Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CTORCTOR
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CITIUS ONCOLOGY INC

CITADEL ADVISORS LLC holds 90,586 shares of CTOR (CITIUS ONCOLOGY INC), worth $58,890 as of 2026-Q2. This is a new position.

Current Value

$58,890

Current Shares

90,586

Total Value Change

+$32,786

Total Shares Change

+67,887

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
90,586
-
$58,8900.0%$0.65
32
2025-Q4
Exited
0
-100.0%
$00.0%$1.05
0
2025-Q3
New
17,661
-
$35,8520.0%$2.03
30
2025-Q1
Exited
0
-100.0%
$00.0%$0.67
0
2024-Q4
New
22,699
-
$26,1040.0%$1.12
29

Other major holders of CTOR: BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used